
Khatol S. Shahnan Shah
Examiner (ID: 17930, Phone: (571)272-0863 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 691 |
| Issued Applications | 342 |
| Pending Applications | 101 |
| Abandoned Applications | 266 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17609820
[patent_doc_number] => 20220152099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => Method for the preparation of an anti-streptococcus serum for use in the treatment of Coronavirus-related diseases.
[patent_app_type] => utility
[patent_app_number] => 16/951906
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16951906
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/951906 | Method for the preparation of an anti-streptococcus serum for use in the treatment of Coronavirus-related diseases. | Nov 17, 2020 | Abandoned |
Array
(
[id] => 17154872
[patent_doc_number] => 20210315923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => LIPIDATED PSA COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/088547
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17088547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/088547 | LIPIDATED PSA COMPOSITIONS AND METHODS | Nov 2, 2020 | Pending |
Array
(
[id] => 18314132
[patent_doc_number] => 11628192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/082668
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 3995
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082668
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/082668 | None | Oct 27, 2020 | Issued |
Array
(
[id] => 16807865
[patent_doc_number] => 20210130418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => CLAUDIN-TARGETING AGENTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/073817
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073817
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073817 | Claudin-targeting agents and uses thereof | Oct 18, 2020 | Issued |
Array
(
[id] => 18003602
[patent_doc_number] => 20220362368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/764434
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764434 | STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE | Oct 1, 2020 | Abandoned |
Array
(
[id] => 18003542
[patent_doc_number] => 20220362308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => ORAL ADMINISTRATION OF GENETICALLY ENGINEERED BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/763014
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17391
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763014
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763014 | ORAL ADMINISTRATION OF GENETICALLY ENGINEERED BACTERIA | Sep 23, 2020 | Abandoned |
Array
(
[id] => 16620009
[patent_doc_number] => 20210038662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => Algal extract comprising sulphated and non-sulphated polyanionic polysaccharides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/028768
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/028768 | Algal extract comprising sulphated and non-sulphated polyanionic polysaccharides and uses thereof | Sep 21, 2020 | Issued |
Array
(
[id] => 17988903
[patent_doc_number] => 20220354940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => BEE VACCINES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/762009
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762009 | BEE VACCINES AND METHODS OF USE | Sep 16, 2020 | Pending |
Array
(
[id] => 19529523
[patent_doc_number] => 20240353425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => Method for diagnosis of lung disease based on antibodies for microbial-derived vesicles
[patent_app_type] => utility
[patent_app_number] => 17/641841
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641841
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641841 | Method for diagnosis of lung disease based on antibodies for microbial-derived vesicles | Aug 30, 2020 | Abandoned |
Array
(
[id] => 16776603
[patent_doc_number] => 20210113680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Multivalent VLP Conjugates
[patent_app_type] => utility
[patent_app_number] => 16/987998
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16987998
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/987998 | Multivalent VLP Conjugates | Aug 6, 2020 | Abandoned |
Array
(
[id] => 17837760
[patent_doc_number] => 20220275065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => MULTIVALENT DNA ANTIBODY CONSTRUCTS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/631691
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631691 | Multivalent DNA antibody constructs and use thereof | Jul 30, 2020 | Issued |
Array
(
[id] => 17830412
[patent_doc_number] => 20220267716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/632449
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -521
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632449
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632449 | METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA | Jul 30, 2020 | Pending |
Array
(
[id] => 17387067
[patent_doc_number] => 20220034919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => System and Method of Automatically Preparing and Analyzing Urine Samples for Identifying Cancer Cells
[patent_app_type] => utility
[patent_app_number] => 16/945278
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16945278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/945278 | System and Method of Automatically Preparing and Analyzing Urine Samples for Identifying Cancer Cells | Jul 30, 2020 | Abandoned |
Array
(
[id] => 20535957
[patent_doc_number] => 12553023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Homogenisation process for the preparation of a cellular component homogenate
[patent_app_type] => utility
[patent_app_number] => 17/630448
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6104
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630448
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630448 | Homogenisation process for the preparation of a cellular component homogenate | Jul 29, 2020 | Issued |
Array
(
[id] => 16435526
[patent_doc_number] => 20200352851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHOD OF TREATING AN EYE DISORDER BY INHIBITING OR DISRUPTING BACTERIAL BIOFILM FORMATION
[patent_app_type] => utility
[patent_app_number] => 16/942980
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16942980
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/942980 | METHOD OF TREATING AN EYE DISORDER BY INHIBITING OR DISRUPTING BACTERIAL BIOFILM FORMATION | Jul 29, 2020 | Abandoned |
Array
(
[id] => 16711901
[patent_doc_number] => 20210079048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/939100
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939100
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939100 | VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS | Jul 26, 2020 | Abandoned |
Array
(
[id] => 17828499
[patent_doc_number] => 20220265803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITIONS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/630841
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630841
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630841 | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITIONS AND METHODS OF USING THE SAME | Jul 26, 2020 | Pending |
Array
(
[id] => 16583172
[patent_doc_number] => 20210017574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => METHOD FOR ASSESSING THE LETHALITY AND THE LEVEL OF CROSS CONTAMINATION CONTROL OF A PROCESS NON-INVASIVELY
[patent_app_type] => utility
[patent_app_number] => 16/933720
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933720
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/933720 | METHOD FOR ASSESSING THE LETHALITY AND THE LEVEL OF CROSS CONTAMINATION CONTROL OF A PROCESS NON-INVASIVELY | Jul 19, 2020 | Pending |
Array
(
[id] => 17865400
[patent_doc_number] => 20220288135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/625040
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 110605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -167
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625040 | LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODS | Jul 7, 2020 | Abandoned |
Array
(
[id] => 20401261
[patent_doc_number] => 12491221
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/769330
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 601
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769330 | None | Jun 30, 2020 | Issued |